Premium
Somatic mutations identified at diagnosis by exome sequencing can predict response to imatinib in chronic phase chronic myeloid leukemia (CML) patients
Author(s) -
Mologni Luca,
Piazza Rocco,
Khandelwal Praveen,
Pirola Alessandra,
GambacortiPasserini Carlo
Publication year - 2017
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.24865
Subject(s) - medicine , imatinib mesylate , imatinib , myeloid leukemia , oncology , trisomy 8 , philadelphia chromosome , cytogenetics , chromosome , genetics , biology , chromosomal translocation , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom